VTRS: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/a3d8c8db-4f95-43a1-82cf-69cd72fdb75a/","filing_uuid":"a3d8c8db-4f95-43a1-82cf-69cd72fdb75a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/a3d8c8db-4f95-43a1-82cf-69cd72fdb75a/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"R. Paul Stimers, Partner","dt_posted":"2026-07-13T07:51:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 17th Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":18466,"url":"https://lda.gov/api/v1/registrants/18466/","house_registrant_id":30825,"name":"HOLLAND & KNIGHT LLP","description":"Law Firm","address_1":"800 17th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RICHARD GOLD","contact_telephone":"+1 202-955-3000","dt_updated":"2026-07-30T20:48:41.410941-04:00"},"client":{"id":204241,"url":"https://lda.gov/api/v1/clients/204241/","client_id":1009747,"name":"VIATRIS INC","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-03-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58154,"prefix":null,"prefix_display":null,"first_name":"MIRANDA","nickname":null,"middle_name":null,"last_name":"FRANCO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47502,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"WERNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148957,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"BROSSI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}